Adia Med, Inc.
corporate_fare Company Profile
Adia Med, Inc. (OTC:ADIA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 10 items for ADIA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for ADIA spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- Adia Med Q3 10-Q: Going Concern Warning Persists Despite Revenue Nearly Doubling
- CEO Buys 7% of Adia Labs Subsidiary for $350K Cash in Related-Party Deal
- Adia Med Sells 30% of Adia Labs for $1.5M, Cedes Equal Voting Control
- Adia Med Moves to Cancel 30.78% of Its Own Shares as Invalidly Issued
- Adia Nutrition Q2 2026: Going Concern Warning, Ineffective Controls, and New Preferred Issuance
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 1,460 shares in ADIA as of the October 30, 2026 settlement, a 91.8% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 19, 2026, 50.6% of ADIA volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.